Sign In
Buy CFMS
$2.26
+0 (+0%)
At Close: Nov 30, 2023
Conformis Reports Third Quarter 2020 Financial Results
04:10pm, Wednesday, 04'th Nov 2020
BILLERICA, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020.
Earnings Outlook for Conformis
10:09am, Tuesday, 03'rd Nov 2020
Conformis (NASDAQ: CFMS) releases its next round of earnings this Wednesday, November 04. Get the latest predictions in Benzinga's essential guide to the company's Q3 earnings report.
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
06:30pm, Wednesday, 28'th Oct 2020
BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, wi
Conformis (CFMS) Investor Presentation - Slideshow
01:49pm, Friday, 14'th Aug 2020
The following slide deck was published by Conformis, Inc. in conjunction with this event..
Conformis Announces Farzin Khaghani as VP, US Marketing; Inducement Grants Reported
09:15pm, Thursday, 13'th Aug 2020
BILLERICA, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani as its new VP, US Marketing. “We are very pleased to
90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements
01:25pm, Monday, 10'th Aug 2020
Clinical research published online in July 2020 in The Journal of Bone and Joint Surgery Reviews found that the patients studied, who all received Conformis patient-specific iTotal PS (posterior-stabi
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
12:45am, Thursday, 06'th Aug 2020
ConforMIS (CFMS) delivered earnings and revenue surprises of 76.92% and 32.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical Centers
08:10pm, Wednesday, 05'th Aug 2020
BILLERICA, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Summary * Total r
Flexion Therapeutics: An Orthopedic Surgeon And Zilretta User Says Short The Stock
02:00pm, Thursday, 30'th Jul 2020
Currently available studies show minimal clinical improvement compared to traditional cortisone based on primary data points.
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
09:00pm, Thursday, 23'rd Jul 2020
BILLERICA, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is bein
ConforMIS (CFMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
04:32pm, Wednesday, 22'nd Jul 2020
ConforMIS (CFMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bullish: Analysts Just Made A Substantial Upgrade To Their Conformis, Inc. (NASDAQ:CFMS) Forecasts
11:00am, Wednesday, 08'th Jul 2020
Shareholders in Conformis, Inc. (NASDAQ:CFMS) may be thrilled to learn that the analysts have just delivered a major...
Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit Agreement
11:30am, Monday, 06'th Jul 2020
Conformis, Inc. (CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit eac
JPMorgan Chase & Co. Sells 354,198 Shares of ConforMIS Inc (NASDAQ:CFMS)
04:04am, Sunday, 05'th Jul 2020
JPMorgan Chase & Co. trimmed its position in ConforMIS Inc (NASDAQ:CFMS) by 58.5% in the first quarter, according to its most recent filing with the SEC. The fund owned 251,586 shares of the medical i
Conformis Next-Generation Identity PS Knee System Gets FDA Nod
01:50pm, Wednesday, 24'th Jun 2020
Conformis' (CFMS) latest iTotal Identity PS Knee System clears FDA hurdle, paving the way for providing better patient-specific pre-operative surgical plans.
